Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Lansoprazole/tacrolimus/voriconazole interaction

Decreased drug concentrations and graft-versus-host disease: case report

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      Iwamoto T, Monma F, Fujieda A, Nakatani K, Katayama N, Okuda M.Hepatic drug interaction between tacrolimus and lansoprazole in a bone marrow transplant patient receiving voriconazole and harboring CYP2C19 and CYP3A5 heterozygous mutations. Clinical Therapeutics 33: 1077-1080, No. 8, Aug 2011. Available from: URL: http://dx.doi.org/10.1016/j.clinthera.2011.07.006 - Japan

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Lansoprazole/tacrolimus/voriconazole interaction. React. Wkly. 1372, 23 (2011). https://doi.org/10.2165/00128415-201113720-00074

    Download citation

    Keywords

    • Tacrolimus
    • Voriconazole
    • Lansoprazole
    • Anaplastic Large Cell Lymphoma
    • Blood Tacrolimus Concentration